Dialectica publishes 2026 healthcare software market report

Dialectica has published a 2026 expert report on the healthcare software market, covering market size, sector trends, and SaaS-specific dynamics. The piece is hosted on the firm's blog and authored by a content marketing specialist rather than an industry analyst.

The report sits in a now-familiar genre: the vertical primer published by an expert network as a top-of-funnel asset. GLG, Third Bridge, AlphaSense, and Guidepoint all run versions of the same play. The thesis is that buy-side analysts ramping into a new sector want a structured starting point, and the network that supplies the primer is the one they call when they need experts.

What distinguishes the better examples in this category is sourcing density and methodology disclosure. The public-facing version of Dialectica's report visible at the URL above is light on both. There are no cited market-size figures, no segmentation by sub-vertical (EHR, RCM, clinical decision support, patient engagement, payer software), no growth-rate ranges, and no named comparable transactions in the snippet that loads. Whether the gated or full version goes deeper is the question, and the firm has not made that distinction explicit on the landing page.

Healthcare software is a reasonable vertical to anchor a 2026 primer around. The category covers public names (Veeva, Doximity, Hims & Hers, Phreesia, Definitive Healthcare) and a long tail of private SaaS builders selling into hospitals, physician groups, and payers. SaaS-specific dynamics in this vertical, including long sales cycles, EHR integration friction, regulatory drag from HIPAA and state privacy law, and the slow but real shift toward usage-based pricing in clinical AI products, are genuinely different from horizontal SaaS. A primer that addresses these well is useful. One that gestures at them without specifics is a lead magnet.

Watch for two things over the next quarter. First, whether Dialectica follows up with sub-vertical deep dives (RCM, clinical AI, patient engagement) or leaves this as a single broad piece. Sub-vertical specificity is where these primers earn their keep. Second, whether competing networks publish their own 2026 healthcare software reports in the next eight weeks. If they do, this becomes a vertical-content arms race; if they do not, it suggests Dialectica is leaning harder into healthtech as a coverage area worth investing in.